Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.12 +0.01 (+0.90%)
At close: Nov 11, 2026 · 4:00 PM EST

Alx Oncology Holdings (ALXO) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Alx Oncology Holdings (ALXO) posted Return on Capital Employed [ROCE] of -53.33% for Q2 2026, up 82.95 percentage points from -136.28% a year earlier and up 39.22 percentage points from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Alx Oncology Holdings' Return on Capital Employed [ROCE] came in at -131.91%, down 51.27 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for five consecutive years, with a five-year change of -111.80 percentage points (FY2020 to FY2025).
  • In prior years, Alx Oncology Holdings' Return on Capital Employed [ROCE] was -80.64% in FY2024 (-9.25 pp), -71.39% in FY2023 (-30.93 pp), -40.45% in FY2022 (-19.18 pp) and -21.27% in FY2021 (-1.16 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2023.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -24.27 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2026, with a gain of 82.95 percentage points; the weakest was Q4 2025, with a drop of 128.41 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -92.55% (Q1 2026), -224.51% (Q4 2025) and -182.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Alx Oncology Holdings 153.42 Mn -230.55 Mn - -53.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.33%
Mar 31, 2026 -92.55%
Dec 31, 2025 -224.51%
Sep 30, 2025 -182.08%
Jun 30, 2025 -136.28%
Mar 31, 2025 -118.11%
Dec 31, 2024 -96.10%
Sep 30, 2024 -95.26%
Jun 30, 2024 -103.08%
Mar 31, 2024 -90.00%
Dec 31, 2023 -87.17%
Sep 30, 2023 -78.07%
Jun 30, 2023 -56.40%
Mar 31, 2023 -49.88%
Dec 31, 2022 -44.91%
Sep 30, 2022 -40.34%
Jun 30, 2022 -33.72%
Mar 31, 2022 -26.38%
Dec 31, 2021 -22.30%
Sep 30, 2021 -18.32%
API Access

Alx Oncology Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALXO&period=max&api_key=YOUR_API_KEY